$ATLX
Atlas Lithium Corp Stock $atlx

$atlx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224011539 Filed on March 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$186.7K	$0.00
YoY Change
Cost Of Revenue	$102.1K	$0.00
YoY Change
Gross Profit	$84.64K	$0.00
YoY Change
Gross Profit Margin	45.33%
Selling, General & Admin	$10.09M	$14.56M	$25.86M
YoY Change	192.52%	590.04%	419.32%
% of Gross Profit	11923.44%
Research & Development	$3.171M	$4.920M	$16.55M
YoY Change	207.86%
% of Gross Profit	3746.48%
Depreciation & Amortization	$31.91K	$42.88K	$50.74K
YoY Change	694.77%	328.8%	267.53%
% of Gross Profit	37.7%
Operating Expenses	$13.27M	$17.14M	$42.59M
YoY Change	196.17%	620.26%	681.86%
Operating Profit	-$13.18M	-$17.14M	-$42.59M
YoY Change	194.28%	620.26%	673.8%
Interest Expense	$202.7K	$155.0K	$87.42K
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$2.375K	-$46.10K	-$45.88K
YoY Change	-83.05%	-71.19%	-70.56%
Pretax Income	-$13.18M	-$17.03M	-$42.63M
YoY Change	195.26%	570.6%	653.31%
Income Tax
% Of Pretax Income
Net Earnings	-$12.96M	-$17.02M	-$41.39M
YoY Change	226.87%	673.7%	794.31%
Net Earnings / Revenue	-6943.21%
Basic Earnings Per Share	-$1.29		-$4.11
Diluted Earnings Per Share	-$1.29	-$1.23	-$4.11
COMMON SHARES
Basic Shares Outstanding	12.77M shares	10.73M shares	10.07M shares
Diluted Shares Outstanding	10.07M shares		10.07M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.53M	$29.55M	$29.55M
YoY Change	251.29%	10453.55%	10453.55%
Cash & Equivalents	$17.53M	$29.55M	$29.55M
Short-Term Investments
Other Short-Term Assets	$144.7K	$113.9K	$113.9K
YoY Change	189.34%	127.82%	127.82%
Inventory	$21.89K
Prepaid Expenses
Receivables			$0.00
Other Receivables	$11.00K	$50.82K	$50.82K
Total Short-Term Assets	$17.71M	$29.71M	$29.71M
YoY Change	250.22%	8502.62%	8389.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.08M	$6.408M	$6.852M
YoY Change	5407.95%	2845.41%	3014.71%
Goodwill
YoY Change
Intangibles	$7.499M	$7.116M
YoY Change	7.72%	43.14%
Long-Term Investments	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Assets
YoY Change
Total Long-Term Assets	$19.99M	$13.97M	$13.97M
YoY Change	172.71%	161.63%	162.06%
TOTAL ASSETS
Total Short-Term Assets	$17.71M	$29.71M	$29.71M
Total Long-Term Assets	$19.99M	$13.97M	$13.97M
Total Assets	$37.70M	$43.68M	$43.68M
YoY Change	204.35%	668.49%	669.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.992M	$1.954M	$3.407M
YoY Change	216.21%	376.62%	730.94%
Accrued Expenses	$125.0K	$115.0K	$115.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$231.1K	$67.02K	$67.02K
YoY Change
Total Short-Term Liabilities	$6.427M	$5.670M	$5.670M
YoY Change	161.37%	102.64%	102.49%
LONG-TERM LIABILITIES
Long-Term Debt	$9.730M	$9.704M	$9.704M
YoY Change
Other Long-Term Liabilities	$27.31K	$58.58K	$18.99M
YoY Change	-64.21%	-25.82%	23643.74%
Total Long-Term Liabilities	$27.31K	$58.58K	$28.70M
YoY Change	-64.21%	-25.82%	35773.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.427M	$5.670M	$5.670M
Total Long-Term Liabilities	$27.31K	$58.58K	$28.70M
Total Liabilities	$35.10M	$34.37M	$34.79M
YoY Change	1284.4%	1094.62%	771.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$114.6M	-$101.7M
YoY Change	80.37%	70.62%
Common Stock	$12.77K	$12.76K
YoY Change	89.49%	149.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.205M	$8.891M	$8.891M
YoY Change
Total Liabilities & Shareholders Equity	$37.70M	$43.68M	$43.68M
YoY Change	204.35%	668.49%	669.06%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$12.96M	-$17.02M	-$41.39M
YoY Change	226.87%	673.7%	794.31%
Depreciation, Depletion And Amortization	$31.91K	$42.88K	$50.74K
YoY Change	694.77%	328.8%	267.53%
Cash From Operating Activities	-$6.103M	-$8.344M	-$5.029M
YoY Change	66.6%	583.96%	239.7%
INVESTING ACTIVITIES
Capital Expenditures	$5.673M	$5.560M	$6.019M
YoY Change	343.17%	1885.89%	111.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$6.056M	-$5.560M	-$7.082M
YoY Change	374.58%	1885.89%	148.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$31.21M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		20.39M	$41.21M
YoY Change		1456.65%	815.4%
NET CHANGE
Cash From Operating Activities	-$6.103M	-8.344M	-$5.029M
Cash From Investing Activities	-$6.056M	-5.560M	-$7.082M
Cash From Financing Activities		20.39M	$41.21M
Net Change In Cash	-$12.02M	6.487M	$29.27M
YoY Change	-355.36%	-3514.4%	11255.78%
FREE CASH FLOW
Cash From Operating Activities	-$6.103M	-$8.344M	-$5.029M
Capital Expenditures	$5.673M	$5.560M	$6.019M
Free Cash Flow	-$11.78M	-$13.90M	-$11.05M
YoY Change	138.21%	826.99%	155.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001540684
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Investments Investments		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	ATLX	Deferred Consideration From Royalties Sold DeferredConsiderationFromRoyaltiesSold		usd
CY2023	us-gaap	Revenues Revenues		usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023	us-gaap	Gross Profit GrossProfit		usd
CY2022	ATLX	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants		usd
CY2023	ATLX	Issuance Of Sale Of Apollo Resources Common Stock In Connection With Equity Offerings IssuanceOfSaleOfApolloResourcesCommonStockInConnectionWithEquityOfferings		usd
CY2022	ATLX	Issuance Of Common Stock In Connection With Purchase Of Mining Rights IssuanceOfCommonStockInConnectionWithPurchaseOfMiningRights		usd
CY2022	us-gaap	Interest Expense InterestExpense		usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	ATLX	Increase Decrease In Deferred Consideration From Royalties Sold IncreaseDecreaseInDeferredConsiderationFromRoyaltiesSold		usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt		usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt		usd
CY2022	us-gaap	Accretion Expense AccretionExpense		usd
CY2022	us-gaap	Accretion Expense AccretionExpense		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2023Q4	ATLX	Contractual Obligation Due From One To Three Years ContractualObligationDueFromOneToThreeYears		usd
CY2023Q4	ATLX	Contractual Obligation Due From Three To Five Years ContractualObligationDueFromThreeToFiveYears		usd
CY2023Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear		usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-55191
CY2023	dei	Entity Registrant Name EntityRegistrantName	ATLAS LITHIUM CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	39-2078861
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Rua Buenos Aires
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	10 – 14th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Belo Horizonte
CY2023	dei	Entity Address Country EntityAddressCountry	BR
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30.315-570
CY2023	dei	City Area Code CityAreaCode	(833)
CY2023	dei	Local Phone Number LocalPhoneNumber	661-7900
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023	dei	Trading Symbol TradingSymbol	ATLX
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	147012507	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12769581	shares
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29549927	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	280525	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	91	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	50824	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	17705	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	113905	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	47093	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	29714656	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	345414	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6407735	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	217550	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7115644	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4971267	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	444624	usd
CY2022Q4	us-gaap	Investments Investments	150000	usd
CY2023Q4	us-gaap	Assets Assets	43682659	usd
CY2022Q4	us-gaap	Assets Assets	5684231	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4487647	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2776474	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1000060	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	67024	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	114994	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5669725	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2797967	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	9703700	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	336411	usd
CY2023Q4	ATLX	Deferred Consideration From Royalties Sold DeferredConsiderationFromRoyaltiesSold	18600000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	58579	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	78964	usd
CY2023Q4	us-gaap	Liabilities Liabilities	34368415	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2876931	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12763581	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12763581	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5110014	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5110014	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12764	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5111	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	111662522	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62258116	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1119771	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-981040	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101664519	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60270994	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8890997	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1011408	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	423247	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	1795892	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9314244	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2807300	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43682659	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5684231	usd
CY2022	us-gaap	Revenues Revenues	6765	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	63548	usd
CY2022	us-gaap	Gross Profit GrossProfit	-56783	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10303340	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2722197	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	15609698	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2269566	usd
CY2023	us-gaap	Exploration Expense ExplorationExpense	16553830	usd
CY2023	us-gaap	Other General Expense OtherGeneralExpense	121176	usd
CY2022	us-gaap	Other General Expense OtherGeneralExpense	455221	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	42588044	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5446984	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-42588044	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5503767	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-200919	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-155812	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	174608	usd
CY2023	ATLX	Finance Costs Revenue FinanceCostsRevenue	-329651	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-155812	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-42633920	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1240395	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1031059	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-41393525	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4628520	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.11
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.11
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10065572	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10065572	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4610681	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4610681	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-42633920	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5659579	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-270980	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-277659	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-42904900	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5937238	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1372645	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1040488	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41532256	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4896750	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	456866	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3902356	usd
CY2022	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	1000000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2269566	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-277659	usd
CY2022	ATLX	Issuance Of Jupiter Gold Common Stock In Connection With Sales Made Under Private Offerings IssuanceOfJupiterGoldCommonStockInConnectionWithSalesMadeUnderPrivateOfferings	489875	usd
CY2022	ATLX	Issuance Of Sale Of Apollo Resources Common Stock In Connection With Equity Offerings IssuanceOfSaleOfApolloResourcesCommonStockInConnectionWithEquityOfferings	625875	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5659579	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2807300	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2807300	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2807300	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32617582	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32617582	usd
CY2023	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	750000	usd
CY2023	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	750000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2017827	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2017827	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3042	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3971	usd
CY2023	ATLX	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	1156158	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12863263	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-270980	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-42633920	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9314244	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9314244	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-42633920	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5659579	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15609698	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2269566	usd
CY2023	ATLX	Issuance Of Common Stock In Connection With Purchase Of Mining Rights IssuanceOfCommonStockInConnectionWithPurchaseOfMiningRights	750000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	73004	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13806	usd
CY2023	us-gaap	Interest Expense InterestExpense	87422	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	174608	usd
CY2023	ATLX	Intangible Assets Purchases Payables IntangibleAssetsPurchasesPayables	-1080783	usd
CY2022	ATLX	Intangible Assets Purchases Payables IntangibleAssetsPurchasesPayables	2367600	usd
CY2023	ATLX	General Provisions GeneralProvisions	795035	usd
CY2022	ATLX	General Provisions GeneralProvisions	155812	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	150091	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1310	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	4155	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1198	usd
CY2023	us-gaap	Increase Decrease In Customer Advances And Deposits IncreaseDecreaseInCustomerAdvancesAndDeposits	-66812	usd
CY2022	us-gaap	Increase Decrease In Customer Advances And Deposits IncreaseDecreaseInCustomerAdvancesAndDeposits	-29847	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1136876	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-568038	usd
CY2023	ATLX	Increase Decrease In Deferred Consideration From Royalties Sold IncreaseDecreaseInDeferredConsiderationFromRoyaltiesSold	20000000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-20382	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-29962	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5029318	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1480530	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6018873	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	177529	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1063594	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2668827	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7082467	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2846356	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31214660	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4502356	usd
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	10000024	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41214684	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4502356	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	166504	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82279	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29269402	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	257749	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280525	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22776	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29549927	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280525	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zWLym4zJjbZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span style="text-decoration: underline"><span id="xdx_86D_zYb3PjMYrXTj">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	brl
CY2023	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_84E_eus-gaap--DerivativesReportingOfDerivativeActivity_zITS5GGiMEke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zhupqYWBxUTi">Derivative Instruments</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Topic 480 of the FASB ASC and Topic 815 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the Statement of Operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p>
CY2023	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	greater than 50%
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zZgLEtn7WLz8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span style="text-decoration: underline"><span id="xdx_869_zO3WFMyVsy2l">Reclassifications</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings (loss) or financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">adoption will have on its consolidated financial statements.</span></p>
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6407735	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6407735	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	659282	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	441732	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	217550	usd
CY2023	us-gaap	Depreciation Depreciation	50741	usd
CY2022	us-gaap	Depreciation Depreciation	13806	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7115644	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4971267	usd
CY2023Q1	us-gaap	Area Of Land AreaOfLand	45.77
CY2023Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	3406864	usd
CY2022Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	408874	usd
CY2023Q4	ATLX	Mineral Rights Payable Current And Noncurrent MineralRightsPayableCurrentAndNoncurrent	1080783	usd
CY2022Q4	ATLX	Mineral Rights Payable Current And Noncurrent MineralRightsPayableCurrentAndNoncurrent	2367600	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	4487647	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2776474	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2023Q4	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	311695	usd
CY2023	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	486304	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	174608	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2517300	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	466887	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	5025	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	20507	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	451405	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	114994	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	336411	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	144132000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	151060000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	138305000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	92965000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	526462000	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	9770724	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	67024	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	9703700	usd
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	67024	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	15395	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1000060	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	58579	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	78964	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	reverse stock split of our issued and outstanding shares of common stock at a ratio of 1-for-750 (the “Reverse Stock Split”). Following the Reverse Stock Split, each 750 shares of our issued and outstanding shares of common stock were automatically converted into one issued and outstanding share of common stock, without any change in par value per share
CY2023Q1	us-gaap	Area Of Land AreaOfLand	45.77
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	321770	shares
CY2023	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	853397	usd
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	10799884	usd
CY2023Q4	ATLX	Contractual Obligation Due In Less Twelve Months ContractualObligationDueInLessTwelveMonths	10799884	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1954145	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1462405	usd
CY2023	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_807_eus-gaap--LossContingencyDisclosures_zJsTUy8u0v8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE 8 – <span id="xdx_823_zCt9IS59dyk5">RISKS AND UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span style="text-decoration: underline">Currency Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company operates primarily in Brazil which exposes it to currency risks. The Company’s business activities may generate intercompany receivables or payables that are in a currency other than the functional currency of the entity. Changes in exchange rates from the time the activity occurs to the time payments are made may result in the Company receiving either more or less in local currency than the local currency equivalent at the time of the original activity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s consolidated financial statements are denominated in U.S. dollars. Accordingly, changes in exchange rates between the applicable foreign currency and the U.S. dollar affect the translation of each foreign subsidiary’s financial results into U.S. dollars for purposes of reporting in the consolidated financial statements. The Company’s foreign subsidiaries translate their financial results from the local currency into U.S. dollars in the following manner: (a) income statement accounts are translated at average exchange rates for the period; (b) balance sheet asset and liability accounts are translated at end of period exchange rates; and (c) equity accounts are translated at historical exchange rates. Translation in this manner affects the shareholders’ equity account referred to as the foreign currency translation adjustment account. This account exists only in the foreign subsidiaries’ U.S. dollar balance sheets and is necessary to keep the foreign subsidiaries’ balance sheets in agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>

Files In Submission

Name	View Source	Status
0001493152-24-011539-index-headers.html	Edgar Link	pending
0001493152-24-011539-index.html	Edgar Link	pending
0001493152-24-011539.txt	Edgar Link	pending
0001493152-24-011539-xbrl.zip	Edgar Link	pending
atlx-20231231.xsd	Edgar Link	pending
atlx-20231231_cal.xml	Edgar Link	unprocessable
atlx-20231231_def.xml	Edgar Link	unprocessable
atlx-20231231_lab.xml	Edgar Link	unprocessable
atlx-20231231_pre.xml	Edgar Link	unprocessable
ex10-6.htm	Edgar Link	pending
ex21.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_014.jpg	Edgar Link	pending
form10-k_015.jpg	Edgar Link	pending
form10-k_016.jpg	Edgar Link	pending
form10-k_017.jpg	Edgar Link	pending
form10-k_018.jpg	Edgar Link	pending
form10-k_019.jpg	Edgar Link	pending
form10-k_020.jpg	Edgar Link	pending
form10-k_021.jpg	Edgar Link	pending
form10-k_022.jpg	Edgar Link	pending
form10-k_023.jpg	Edgar Link	pending
form10-k_024.jpg	Edgar Link	pending
form10-k_025.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATLX
Atlas Lithium Corp Stock $atlx

2024 Q1 Form 10-K Financial Statement

#000149315224011539 Filed on March 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATLX Atlas Lithium Corp Stock $atlx

2024 Q1 Form 10-K Financial Statement

#000149315224011539 Filed on March 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATLX
Atlas Lithium Corp Stock $atlx